Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.
In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future
Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.
Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.
AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.
Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.
That places AMIC right in the middle of a potential growth boom.
While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.
In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.
Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.
Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.
It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.
Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.
Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.
Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.
That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.
Still a developing story worth monitoring.
Disclosure: No position.
Follow ADMD developments and other small cap stocks at VFCsStockHouse.com
Contact VFC's Stock House: email@example.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Cameron: EU has secured 1 billion for Ebola fight
24 Oct 2014 at 3:27am
BRUSSELS (AP) ? British Prime Minister David Cameron says that the European Union and its 28 member nations have secured 1 billion euros ($1.25 billion) to fight the Ebola crisis in West Africa.
WHO sending Ebola experts to Mali, 43 people monitored for virus
24 Oct 2014 at 3:10am
GENEVA (Reuters) - The World Health Organization (WHO) said on Friday it was sending experts to help Mali fight Ebola, a day after the first case of the disease was confirmed there. Authorities said on Thursday a two-year-old girl was infected - making Mali the sixth West African country to be touched by the worst outbreak on record of the hemorrhagic fever, which has killed nearly 4,900 people.. A WHO team of three experts has been in Mali evaluating its defenses, and at least four more would set off over the next few days, WHO spokeswoman Fadela Chaib said. ...
EU leaders agree to raise Ebola aid budget to 1 bln euros
24 Oct 2014 at 3:01am
BRUSSELS (Reuters) - European Union leaders agreed on Friday to roughly double their financial support for efforts to fight the deadly Ebola epidemic in Africa to 1 billion euros, the chairman of their Brussels summit, European Council President Herman Van Rompuy, said. "EU will increase financial help to 1 billion euros to fight Ebola in West Africa," he said in a Twitter messsage. Total contributions from the 28 nations had been running at about 500 million euros ($630 million) and there had been criticism that the wealthy Europeans were not doing more. (1 US dollar = 0.7908 euro)
EU leaders agree to raise Ebola aid budget to 1 billion euros
24 Oct 2014 at 3:00am
BRUSSELS (Reuters) - European Union leaders agreed on Friday to roughly double their financial support for efforts to fight the deadly Ebola epidemic in Africa to 1 billion euros, the chairman of their Brussels summit, European Council President Herman Van Rompuy, said. "EU will increase financial help to 1 billion euros to fight Ebola in West Africa," he said in a Twitter message. Total contributions from the 28 nations had been running at about 500 million euros ($630 million) and there had been criticism that the wealthy Europeans were not doing more. (1 US dollar = 0. ...
Britons had less gum disease in Roman times than today: study
24 Oct 2014 at 2:36am
Britons had far less gum disease in the Roman era than today, and oral health has seriously worsened despite the advent of toothbrushes and dentists, a study said Friday.
Australian doctors transplant 'dead' hearts in surgical breakthrough
24 Oct 2014 at 2:04am
Sydney (AFP) - Australian surgeons said Friday they have used hearts which had stopped beating in successful transplants, in what they said was a world first that could change the way organs are donated.
Doctor with Ebola in Manhattan hospital after return from Guinea
24 Oct 2014 at 1:07am
By Ellen Wulfhorst and Sebastien Malo NEW YORK (Reuters) - A doctor who worked in West Africa with Ebola patients was in an isolation unit in New York on Friday after testing positive for the deadly virus, becoming the fourth person diagnosed with the disease in the United States and the first in its largest city. The worst Ebola outbreak on record has killed at least 4,900 people and perhaps as many as 15,000, mostly in Liberia, Sierra Leone and Guinea, according to World Health Organization figures. ...
Watch: Ohio College Student Diagnosed with Brain Cancer Receives Final Wish
24 Oct 2014 at 1:07am
Lauren Hill, 19, will get to play one last game of college basketball with her Mount St Joe's team.
Official cites 'epidemic of fear' in US
24 Oct 2014 at 12:49am
WASHINGTON (AP) ? The likelihood of a significant outbreak of Ebola in the U.S. is remote, in the view of a top Health and Human Services official who is assuring lawmakers that government agencies are preparing for any contingency.
Hikma Pharma says US FDA issues warning on Portugal plant
24 Oct 2014 at 12:34am
(Reuters) - Drugmaker Hikma Pharmaceuticals Plc said the U.S. health regulator had raised issues related to investigations and environmental monitoring at its plant in Portugal. The Jordanian company said it had received a warning letter from the U.S. Food and Drug Administration on Thursday following an inspection of the plant in March. Shares in the company, which makes and markets branded and non-branded generics and injectibles, fell 3.5 percent in early trading on the London Stock Exchange on Friday. Hikma produces powder, liquid and lyophilized injectible drugs at the Portugal plant. ...
Cash aid for refugees succeeds despite donors' doubts
24 Oct 2014 at 12:23am
By Oliver Holmes BEIRUT (Reuters) - For decades, aid groups have assumed they know what's best for refugees and the poor; a growing body of evidence suggests they're wrong. Both academic research and practical experience, such as with the mass of Syrians fleeing civil war, shows that simply handing out traditional relief goods may not be the most effective way of helping the dispossessed. Aid agencies are tentatively also giving away cash and letting refugees decide for themselves what they need. ...
'Clever' Japan firm donates high-tech masks for Ebola fight
24 Oct 2014 at 12:21am
A little-known Japanese company has donated 10,000 high-tech face masks to several Ebola-hit African nations and says it is now getting calls from New York City, which confirmed its first case of the virus Thursday. Clever, a maker of air filters, said it is sending thousands of the $75 masks for use by doctors and other health professionals in Guinea, Liberia and the Democratic Republic of the Congo. "We got a call from the government of Guinea asking for our product," said Tsuyoshi Nakagawara, a board member of the firm which is based in central Aichi prefecture, a major industrial centre. Clever says its Pittarich mask -- originally developed for the Middle East respiratory syndrome coronavirus, known as the MERS -- is coated in chemicals that kill 99 percent of viruses, including Ebola, when they come into contact with the specialised device.
Nigeria pledges 600 volunteers as Africa steps up Ebola fight
24 Oct 2014 at 12:20am
By Felix Onuah and Umaru Fofana ABUJA/FREETOWN (Reuters) - Nigeria pledged on Thursday to send a contingent of 600 volunteers to help fight the worst ever outbreak of Ebola on record which has killed nearly 5,000 people in West Africa. With financial pledges flowing in from around the world but trained doctors and nurses scarce in the three worst effected countries -- Liberia, Guinea and Sierra Leone, the African Union appealed last week to member states to urgently fill the gap. ...
Mali becomes sixth West African nation hit by Ebola
24 Oct 2014 at 12:06am
By Adama Diarra and Tiemoko Diallo BAMAKO (Reuters) - Mali confirmed its first case of Ebola on Thursday, becoming the sixth West African country to be touched by the worst outbreak on record of the haemorrhagic fever, which has killed nearly 4,900 people. Mali's Health Minister Ousmane Kone told state television that the patient in the western town of Kayes was a two-year-old girl who had recently arrived from neighbouring Guinea, where the outbreak began. "The condition of the girl, according to our services, is improving thanks to her rapid treatment," the minister told state television. ...
Doctor who worked in Africa first Ebola case in New York City
23 Oct 2014 at 11:33pm
By Ellen Wulfhorst NEW YORK (Reuters) - A New York City doctor who treated Ebola patients in West Africa became the first person to test positive for the virus in America's largest city, setting off fresh fears about the spread of the disease. New York Mayor Bill de Blasio said residents were safe to travel around the city, even as officials disclosed that Dr. Craig Spencer had ridden subways, taken a taxi and visited a bowling alley since returning from Guinea on Oct. 17. Spencer, 33, had worked with the humanitarian organization Doctors Without Borders in Africa. ...